omega-n-methylarginine has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, SJ; Kang, JH; Lee, J; Lee, JW; Lee, MH; Moon, EY; Ryu, YK | 1 |
| Bättig, U; Cakmakci, M; Geroulanos, S; Schilling, J | 1 |
| Mehta, JL; Yang, BC | 1 |
| Briscoe, H; Britton, WJ; Meadows, N; Rathjen, D; Roach, DR | 1 |
4 other study(ies) available for omega-n-methylarginine and Recrudescence
| Article | Year |
|---|---|
γ-Irradiated cancer cells promote tumor growth by activation of Toll-like receptor 1-mediated inducible nitric oxide synthase in macrophages.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Bone Marrow Cells; Cell Line, Tumor; Chlorocebus aethiops; Coculture Techniques; Colonic Neoplasms; COS Cells; Disease Progression; Enzyme Induction; Gamma Rays; Macrophages; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Recurrence; Toll-Like Receptor 1; Tumor Microenvironment | 2015 |
A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Pressure; Cardiac Output; Combined Modality Therapy; Critical Care; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Necrosis; Nitric Oxide Synthase; omega-N-Methylarginine; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Shock, Septic; Staphylococcal Infections | 1993 |
Prior episode of anoxia attenuates vasorelaxation in response to subsequent episode of anoxia.
Topics: Adenosine; Animals; Aorta; Arginine; Calcium; Endothelium, Vascular; Free Radicals; Hypoxia; In Vitro Techniques; Nitric Oxide; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Purinergic P1 Receptor Antagonists; Rats; Recurrence; Vasodilation | 1994 |
A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Bone Marrow Cells; CD4-Positive T-Lymphocytes; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Immunologic Factors; Interferon-gamma; Lymphocyte Depletion; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Peptide Fragments; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Recurrence; Specific Pathogen-Free Organisms; Tuberculoma; Tuberculosis; Tumor Necrosis Factor-alpha | 2000 |